See more : GeoVax Labs, Inc. (GOVX) Income Statement Analysis – Financial Results
Complete financial analysis of Japan Tobacco Inc. (2914.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Japan Tobacco Inc., a leading company in the Tobacco industry within the Consumer Defensive sector.
- Changzhou Zhongying Science & Technology Co., Ltd (300936.SZ) Income Statement Analysis – Financial Results
- Isuzu Motors Limited (ISUZY) Income Statement Analysis – Financial Results
- Koramco Energy Plus Reit (357120.KS) Income Statement Analysis – Financial Results
- Comet Holding AG (0ROQ.L) Income Statement Analysis – Financial Results
- Newpath Resources Inc. (RDYFF) Income Statement Analysis – Financial Results
Japan Tobacco Inc. (2914.T)
About Japan Tobacco Inc.
Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, prescription drugs, and processed foods in Japan and internationally. The company operates through four segments: Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. It offers tobacco products, such as cigarettes, cigars, pipe tobacco, oral tobacco, waterpipe tobacco, kretek, and fine cut products under the Winston, Camel, MEVIUS, and LD brands. The company also provides reduced-risk products, including tobacco-infused vapor and heated tobacco products, E-Vapor products, etc. under the Ploom, Logic, Ploom TECH, Ploom TECH+, and Ploom S brands. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, renal and metabolism, immunology, and neuroscience. Further, the company provides staple food products, such as frozen noodles and okonomiyaki, and frozen and packed cooked rice; ambient processed foods; bakery products; and seasonings, including yeast extracts and oyster sauce. Japan Tobacco Inc. was founded in 1898 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,841.08B | 2,657.83B | 2,324.84B | 2,092.56B | 2,175.63B | 2,215.96B | 2,139.65B | 2,143.29B | 2,252.88B | 2,019.75B | 2,399.84B | 2,120.20B | 2,033.83B | 6,194.55B | 6,134.70B | 6,832.31B | 6,409.73B | 4,769.39B | 4,637.66B | 4,664.51B | 4,625.15B | 4,492.26B | 4,544.18B |
| Cost of Revenue | 1,225.97B | 1,090.99B | 956.86B | 898.00B | 942.30B | 933.03B | 843.56B | 872.43B | 920.06B | 822.54B | 979.98B | 899.39B | 892.03B | 5,074.07B | 5,022.64B | 5,554.40B | 5,228.93B | 3,844.77B | 3,734.07B | 3,713.73B | 3,684.01B | 3,569.39B | 3,598.80B |
| Gross Profit | 1,615.10B | 1,566.84B | 1,367.98B | 1,194.56B | 1,233.33B | 1,282.93B | 1,296.10B | 1,270.85B | 1,332.83B | 1,197.21B | 1,419.87B | 1,220.80B | 1,141.79B | 1,120.48B | 1,112.06B | 1,277.91B | 1,180.80B | 924.62B | 903.58B | 950.79B | 941.14B | 922.87B | 945.38B |
| Gross Profit Ratio | 56.85% | 58.95% | 58.84% | 57.09% | 56.69% | 57.89% | 60.58% | 59.29% | 59.16% | 59.28% | 59.17% | 57.58% | 56.14% | 18.09% | 18.13% | 18.70% | 18.42% | 19.39% | 19.48% | 20.38% | 20.35% | 20.54% | 20.80% |
| Research & Development | 75.10B | 70.81B | 65.02B | 60.85B | 64.08B | 65.38B | 60.60B | 58.19B | 57.80B | 58.68B | 57.10B | 56.86B | 51.46B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 541.60B | 941.54B | 888.57B | 784.47B | 831.71B | 770.41B | 786.91B | 754.12B | 789.35B | 752.56B | 828.94B | 733.39B | 27.92B | 791.80B | 815.55B | 914.10B | 750.25B | 592.63B | 596.64B | 677.42B | 707.10B | 733.91B | 781.57B |
| Selling & Marketing | 237.79B | 233.37B | 204.84B | 177.02B | 191.03B | 188.06B | 218.03B | 228.53B | 224.10B | 255.18B | 218.82B | 199.20B | 190.50B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 779.39B | 941.54B | 888.57B | 784.47B | 831.71B | 770.41B | 786.91B | 754.12B | 789.35B | 752.56B | 828.94B | 733.39B | 218.42B | 791.80B | 815.55B | 914.10B | 750.25B | 592.63B | 596.64B | 677.42B | 707.10B | 733.91B | 781.57B |
| Other Expenses | 0.00 | -20.26B | -15.62B | -54.92B | -95.73B | -48.53B | -45.72B | -70.10B | -15.37B | 0.00 | 0.00 | -99.03B | 293.61B | 0.00 | -5.74B | -47.58B | 0.00 | 0.00 | 0.00 | 0.00 | -53.11B | 0.00 | -77.75B |
| Operating Expenses | 854.49B | 921.28B | 872.95B | 729.55B | 735.98B | 721.88B | 741.19B | 684.01B | 773.98B | 752.56B | 773.31B | 691.22B | 563.49B | 791.80B | 815.55B | 914.10B | 750.25B | 592.63B | 596.64B | 677.42B | 707.10B | 733.91B | 781.57B |
| Cost & Expenses | 2,168.67B | 2,012.27B | 1,829.81B | 1,627.55B | 1,678.28B | 1,654.91B | 1,584.75B | 1,556.45B | 1,694.04B | 1,575.10B | 1,753.28B | 1,590.61B | 1,455.53B | 5,865.87B | 5,838.19B | 6,468.50B | 5,979.17B | 4,437.40B | 4,330.71B | 4,391.14B | 4,391.12B | 4,303.30B | 4,380.37B |
| Interest Income | 41.98B | 31.15B | 19.01B | 12.35B | 8.40B | 5.75B | 4.78B | 6.62B | 15.02B | 13.81B | 8.35B | 5.49B | 5.60B | 3.03B | 6.98B | 12.28B | 13.41B | 12.10B | 0.00 | 2.02B | 3.24B | 3.74B | 4.70B |
| Interest Expense | 95.22B | 91.27B | 45.65B | 61.34B | 45.53B | 39.25B | 27.35B | 21.71B | 15.13B | 11.16B | 20.41B | 28.29B | 23.43B | 17.06B | 26.11B | 51.36B | 41.76B | 6.94B | 5.78B | 5.15B | 8.14B | 8.55B | 10.27B |
| Depreciation & Amortization | 179.65B | 199.37B | 187.00B | 179.29B | 183.32B | 158.10B | 144.84B | 140.15B | 139.06B | 122.17B | 132.92B | 116.46B | 118.85B | 212.76B | 230.20B | 282.41B | 171.54B | 132.64B | 126.45B | 126.74B | 153.59B | 148.33B | 170.31B |
| EBITDA | 824.78B | 829.17B | 687.13B | 622.71B | 678.00B | 709.95B | 695.86B | 720.93B | 719.30B | 635.86B | 789.53B | 654.17B | 583.63B | 529.15B | 532.36B | 595.91B | 585.91B | 474.24B | 431.62B | 232.34B | 133.76B | 299.38B | 278.83B |
| EBITDA Ratio | 29.03% | 33.27% | 30.33% | 31.59% | 31.93% | 32.92% | 33.24% | 34.56% | 31.93% | 29.13% | 32.90% | 30.86% | 34.55% | 8.79% | 8.61% | 8.94% | 8.58% | 9.34% | 9.27% | 9.82% | 7.30% | 6.60% | 5.75% |
| Operating Income | 672.41B | 653.58B | 499.02B | 469.05B | 502.36B | 564.98B | 561.10B | 593.33B | 565.23B | 466.27B | 648.26B | 532.36B | 408.62B | 328.68B | 296.51B | 363.81B | 430.55B | 312.90B | 306.95B | 273.37B | 234.03B | 148.08B | 163.81B |
| Operating Income Ratio | 23.67% | 24.59% | 21.46% | 22.42% | 23.09% | 25.50% | 26.22% | 27.68% | 25.09% | 23.09% | 27.01% | 25.11% | 20.09% | 5.31% | 4.83% | 5.32% | 6.72% | 6.56% | 6.62% | 5.86% | 5.06% | 3.30% | 3.60% |
| Total Other Income/Expenses | -50.81B | -60.13B | -26.63B | -48.99B | -37.12B | -33.50B | -22.57B | -15.09B | -116.00M | 57.88B | -12.06B | -22.86B | -17.83B | -48.18B | -20.45B | -101.66B | -57.94B | 5.20B | -5.95B | -172.04B | -241.64B | -46.47B | -65.56B |
| Income Before Tax | 621.60B | 593.45B | 472.39B | 420.06B | 465.23B | 531.49B | 538.53B | 578.24B | 565.11B | 502.53B | 636.20B | 509.56B | 441.36B | 280.50B | 276.06B | 262.14B | 372.61B | 337.20B | 300.99B | 101.33B | -7.61B | 142.50B | 98.24B |
| Income Before Tax Ratio | 21.88% | 22.33% | 20.32% | 20.07% | 21.38% | 23.98% | 25.17% | 26.98% | 25.08% | 24.88% | 26.51% | 24.03% | 21.70% | 4.53% | 4.50% | 3.84% | 5.81% | 7.07% | 6.49% | 2.17% | -0.16% | 3.17% | 2.16% |
| Income Tax Expense | 136.29B | 149.28B | 132.21B | 108.03B | 103.61B | 144.06B | 141.78B | 152.46B | 162.39B | 132.81B | 200.91B | 158.04B | 112.80B | 130.89B | 131.30B | 134.97B | 128.38B | 121.41B | 94.90B | 31.57B | -4.81B | 61.81B | 56.73B |
| Net Income | 482.29B | 442.72B | 338.49B | 310.25B | 348.19B | 385.68B | 392.41B | 421.70B | 485.69B | 362.92B | 427.99B | 343.61B | 320.88B | 144.96B | 138.45B | 123.40B | 238.70B | 210.77B | 201.54B | 62.58B | -7.60B | 75.30B | 36.85B |
| Net Income Ratio | 16.98% | 16.66% | 14.56% | 14.83% | 16.00% | 17.40% | 18.34% | 19.68% | 21.56% | 17.97% | 17.83% | 16.21% | 15.78% | 2.34% | 2.26% | 1.81% | 3.72% | 4.42% | 4.35% | 1.34% | -0.16% | 1.68% | 0.81% |
| EPS | 271.69 | 249.45 | 190.76 | 174.88 | 195.97 | 215.31 | 219.10 | 235.47 | 270.54 | 199.67 | 235.48 | 181.07 | 168.50 | 127.07 | 72.26 | 64.41 | 124.59 | 110.01 | 525.42 | 160.45 | -3.97 | 37.53 | 18.43 |
| EPS Diluted | 271.63 | 249.36 | 190.68 | 174.80 | 195.87 | 215.20 | 218.97 | 235.33 | 270.37 | 199.56 | 235.35 | 180.98 | 168.44 | 127.04 | 72.25 | 64.40 | 124.58 | 110.01 | 525.42 | 160.45 | -3.97 | 37.53 | 18.43 |
| Weighted Avg Shares Out | 1.78B | 1.77B | 1.77B | 1.77B | 1.78B | 1.79B | 1.79B | 1.79B | 1.80B | 1.82B | 1.82B | 1.90B | 1.90B | 1.91B | 1.92B | 1.92B | 1.92B | 1.92B | 1.92B | 1.94B | 1.92B | 2.01B | 2.00B |
| Weighted Avg Shares Out (Dil) | 1.78B | 1.78B | 1.78B | 1.77B | 1.78B | 1.79B | 1.79B | 1.79B | 1.80B | 1.82B | 1.82B | 1.90B | 1.91B | 1.92B | 1.92B | 1.92B | 1.92B | 1.92B | 1.92B | 1.94B | 1.92B | 2.01B | 2.00B |
Source: https://incomestatements.info
Category: Stock Reports